Skip to content

RNTX RNTX Current ratio

Current ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.4×+0.1×
Gilead Sciences logo
Gilead SciencesGILD
+0.6×
AbbVie logo
AbbVieABBV
0.8×0.0×
CTO
Citius Oncology, Inc.CTOR
0.5×+0.1×
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
5.8×-2.0×
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
4.6×+1.0×

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+177%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×

Where this comes from

Calculated from RNTX’s reported figures.

Based on the most recent quarter.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's current ratio?
RNTX (RNTX) reported current ratio of 0.4× in Q1 2026.
How has RNTX's current ratio changed year-over-year?
RNTX's current ratio decreased by 71.3% year-over-year, from 1.4× to 0.4×.
What is the long-term trend for RNTX's current ratio?
Over 5 years (2020 to 2025), RNTX's current ratio has grown at a -29.9% compound annual growth rate (CAGR), from 4.1× to 0.7×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.